Product Information
SUMATRIPTAN SUCC 50 MG TABLET is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.3319 per EA under NDC 00378563159. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
50 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378563159
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA077744On Market Since
8/10/2009
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN SUCC 50 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 60.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3319 per EA |
|---|---|
| All-time high | $1.0034 (Mar 11, 2015) |
| All-time low | $0.3029 (Nov 20, 2024) |
| 52-week high | $0.3579 |
| 52-week low | $0.3231 |
| Median price | $0.5572 |
| Average price | $0.5816 |
| Largest weekly change | +31.3% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SUMATRIPTAN SUCC 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN SUCC 50 MG TABLET, manufactured by Mylan Pharmaceuticals Inc., is $0.3319 per EA (NDC 00378563159), effective Jun 24, 2026.
How has the price of SUMATRIPTAN SUCC 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN SUCC 50 MG TABLET has declined 60.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN SUCC 50 MG TABLET?
Since Nov 28, 2013, the NADAC for SUMATRIPTAN SUCC 50 MG TABLET has ranged from a low of $0.3029 (Nov 20, 2024) to a high of $1.0034 (Mar 11, 2015), with a median of $0.5572 per EA.
Are there cheaper alternatives to SUMATRIPTAN SUCC 50 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, SUMATRIPTAN SUCC 50 MG TABLET, is $0.3231 per EA — about 3% below SUMATRIPTAN SUCC 50 MG TABLET.
Who manufactures SUMATRIPTAN SUCC 50 MG TABLET?
SUMATRIPTAN SUCC 50 MG TABLET (NDC 00378563159) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification